INTRODUCTION
Epizootics of Rift Valley fever (RVF) have been reported from many African coun tries in which they tend to occur at intervals of 4 to 15 years (5) . The nature of the reservoir in which the virus is maintained between epizootics is not fully understood. In East Africa, forest dwelling mammals are thought to play a role (5) . In South Africa an enzootic focus, in which the only overt signs of the disease were sporadic abortions in cattle, has been reported (3).
The first reported epizootic of RVF in Zambia was in 1974 and involved cattle and sheep in the Chisamba area (Central Province), parts of the Copperbelt area and in Mazabuka district (Southern Province). The diagnosis of RVF was confirmed by serological tests. Chisamba farmers reported the recurrence of RVF in 1976. In 1978 six confirmed cases of the disease were identified in the Chisamba area. Since then no further cases of RVF have been confirmed (2) .
In September 1982 a pilot serological study was conducted on one commercial farm (Farm A) in the Chisamba area. The results indicated an active but relatively inapparent infection of the sheep, and to a lesser extent cattle, by RVF virus.
As a result of these findings a more detailed sero-epidemiological study was con ducted in 1983 aimed at providing more information on the sero-prevalence rates of RVF antibodies in animals of various age groups. In addition, a retrospective sero logical study was conducted using sera collected in 1981 and 1982 from cattle in the traditional sector.
MATERIALS AND METHODS
Four commercial farms in the Chisamba area were included in the study. Three of these (Farms A, B and C) had experienced clinical cases of RVF during the period 1974-1978. The fourth farm (D) has, over the period 1979 to 1983, built up a sheep flock from a nucleus of imported Dorpers. Prior to 1979 no sheep had been kept on this farm. Further details are given in Table I. For the retrospective study, a stratified sample of 440 serum samples were selec ted from a bank of well documented sera collected during the period 1980 to 1982, so that the four major cattle provinces were represented. Details are given in Table II . Sera were tested using a complement fixation test as described by Broom and Findlay (4). Antigen was prepared commercially* and supplied by courtesy of NAMRU-3, Cairo, Egypt. The acetone-sucrose method was used to extract the antigen from the brains of suckling mice infected with RVF virus. The positive control serum used in the test was prepared at NAMRU-3. Before being tested all serum samples were treated according to the method described by Grift et al. (7) to remove anti complementary factors. This resulted in only a small number of anti-complementary sera during the test. Such sera were excluded from the study. 
RESULTS
The pilot study conducted on Farm A demonstrated the presence of RVF virus in nine (47.4%) of the sampled sheep and in one (2.5%) of the cattle. Both sheep and cattle were of varying ages. Further details are given in Table III . The results obtained during the follow-up study in Chisamba produced findings similar to those obtained in the pilot study. Details are given in Table IV. No sero-positive cases were detected in the retrospective study of cattle in the tra ditional sector. In the absence of evidence to the contrary, it is assumed that the results obtained in this study reflect the presence of specific RVFV antibodies.
The presence of significant levels of complement fixing antibody against RVFV in the flocks and herds studied indicates exposure to the virus. RVF vaccine had not been used on any of the farms during a period of at least four years prior to the study. In any case, it is reported that complement fixing antibodies decline two months after vaccination with inactivated RVF vaccine (1) . Therefore, the presence of anti body would indicate an immune response to natural challenge. Broom and Findlay (4) reported that subsequent to natural infection with RVF virus, complement fixing antibodies persist for six months or more. The conclusion was therefore reached that RVF virus was, at the time of the study, or shortly before, active on the study farms.
Three of the four farms studied (Farms A, B, and C) reported having had clinical cases of RVF during the period 1974 to 1978. Abortions in sheep and higher than normal lamb mortality rates were reported from Farm D at the time of the study and, in the light of our findings, this flock was vaccinated with RVF vaccine. Sub sequent to this, the abortions and lamb mortalities were much reduced.
Assuming that the average duration of detectable antibody levels is six months post-infection then it is estimated that, with the overall sero-prevalence rates detec ted during this study, approximately 30 % of a flock will be infected during the course of a 12 month period. Given the high rate of turnover of sheep populations, a signi ficant proportion of animals will be RVF negative at any point in time, a situation in which an epizootic is possible, given the other predisposing factors necessary.
Our findings imply that RVF virus is established enzootically in the Chisamba area. Whether or not the domestic species studied are acting as maintenance hosts is uncertain. The presence of RVF virus was not, at the time of the study, manifested in epizootic form although it appears that the disease has caused overt problems, at a fairly low incidence, in sheep. This suggests that a situation approaching a host (sheep, cattle)/agent balance has developed and that sheep and cattle could, under such conditions, act as reservoir hosts.
During a period of high rainfall, and thus the presence of large numbers of the vector, the transmission rate and the quantum of infection could increase to such an extent that, when combined with the concomitant climatic stress, this relatively stable situation becomes unbalanced in favour of the agent and an epizootic results.
The sero-prevalence rate in sheep was significantly higher than that found in cattle (p < 0.05). Although the sheep and cattle did not graze together they were rotated in the same areas. All sheep were enclosed at night, often fairly close to a dam. This may have increased exposure to the vector and thus probability of infection. Fur thermore, sheep are more susceptible to infection by the virus (6).
In the sheep, significantly higher (p < .001) sero-prevalence rates were found in animals less than one year of age and proportionally more of the positive serum sam ples from this age group had a lower titre (4) than did those from the older animals. This can be accounted for, at least in part, by the presence of maternally-derived antibodies.
The sero-prevalence rate of RVFV antibodies was significantly lower on Farm D compared with the other three farms (p < .001). It is noted that the flock on Farm D is of recent origin and that the nucleus of the flock was introduced into the area. Presumably this flock has had less exposure to the virus and this may account also for the clinical problems, similar to those produced by RVF, recently reported from this farm.
There was no significant difference between the sero-prevalence rates found in sheep of one year of age and those of sheep of two years of age or more. This is to be expected given the limited duration of detectable antibodies to RVFV following infection.
The uniformly negative results obtained from the testing of sera in the retrospective study indicate that RVF virus antibodies are not present, or are present at low prevalence rates, in cattle in the traditional farming areas. No diagnoses of RVF have been made in these areas. A supplementary point which may be of relevance is that very few sheep are kept by traditional farmers.
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